Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

An Epigenomic Map of Multiple Myeloma Reveals the Importance of Polycomb Gene Silencing for the Malignancy

Prasoon Agarwal, Antonia Kalushkova, PhD, Stefan Enroth, PhD, Mohammad Alzrigat, Anders Österborg, Kenneth Nilsson, MD PhD, Fredrik Öberg, PhD, Helena Jernberg-Wiklund, PhD

Blood (2014) 124 (21): 2192.

https://doi.org/10.1182/blood.V124.21.2192.2192

Published: 2014

Journal Articles

Recurrent Mutations within the Nfkbie gene: A Novel Mechanism for NF-κB Deregulation in Aggressive Chronic Lymphocytic Leukemia

Blood (2014) 124 (21): 297.

https://doi.org/10.1182/blood.V124.21.297.297

Published: 2014

Journal Articles

The DNA Methyltransferase Inhibitor Decitabine Induces DNA Damage, Cell Cycle Arrest and Apoptosis in Multiple Myeloma

Ken Maes, Miguel Lemaire, Jordan Gauthier, Hendrik De Raeve, Eline Menu, PhD, Els Van Valckenborgh, PhD, Helena Jernberg Wiklund, PhD, Karin Vanderkerken, PhD, Elke De Bruyne, PhD

Blood (2012) 120 (21): 1833.

https://doi.org/10.1182/blood.V120.21.1833.1833

Published: 2012

Journal Articles

Combination of the IGF-1 Receptor Inhibitor Picropodophylin and the BH3 Mimetic ABT-737 Has Synergistic Anti-Myeloma Activity

Liesbeth Bieghs, Ken Maes, Els Van Valckenborgh, PhD, Eline Menu, PhD, Hans Erik Johnsen, Mette Nyegaard, PhD, Helena Jernberg Wiklund, PhD, Karin Vanderkerken, PhD, Elke De Bruyne, PhD

Blood (2012) 120 (21): 4010.

https://doi.org/10.1182/blood.V120.21.4010.4010

Published: 2012

Journal Articles

ABT-737 Sensitizes B Cell Tumors for Killing by CD19-Retargeted T Cells,

Hannah S C Karlsson, Camilla Lindqvist, PhD, Gabriella Paul-Wetterberg, Helena Jernberg Wiklund, PhD, Kenneth Nilsson, MD, PhD, Bengt Simonsson, MD, PhD, Per Frisk, MD, PhD, Angelica Loskog, PhD

Blood (2011) 118 (21): 4032.

https://doi.org/10.1182/blood.V118.21.4032.4032

Published: 2011

Journal Articles

IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms

Elke De Bruyne, Tomas J. Bos, Frans Schuit, Els Van Valckenborgh, Eline Menu, Lieven Thorrez, Peter Atadja, Helena Jernberg-Wiklund, Karin Vanderkerken

Blood (2010) 115 (12): 2430–2440.

https://doi.org/10.1182/blood-2009-07-232801

Published: 2010

Includes: Supplemental data

Journal Articles

Selective Inhibition of Glycogen Synthase Kinase-3 by Facilitators of Insulin Response Promotes Proliferation and Survival in Multiple Myeloma Cells.

Helena Jernberg-Wiklund, PhD, Thomas Stromberg, PhD, Anna Hammarberg, Patrik Georgii-Hemming, MD, PhD, Anders Osterborg, MD, PhD, Kenneth Nilsson, MD, PhD

Blood (2007) 110 (11): 4789.

https://doi.org/10.1182/blood.V110.11.4789.4789

Published: 2007

Journal Articles

Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model

Eline Menu, Helena Jernberg-Wiklund, Thomas Stromberg, Hendrik De Raeve, Leonard Girnita, Olle Larsson, Magnus Axelson, Kewal Asosingh, Kenneth Nilsson, Ben Van Camp, Karin Vanderkerken

Blood (2006) 107 (2): 655–660.

https://doi.org/10.1182/blood-2005-01-0293

Published: 2006

Journal Articles

IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G 2 /M-phase accumulation and apoptosis in multiple myeloma cells

Thomas Strömberg, Simon Ekman, Leonard Girnita, Lina Y. Dimberg, Olle Larsson, Magnus Axelson, Johan Lennartsson, Ulf Hellman, Kristina Carlson, Anders Österborg, Karin Vanderkerken, Kenneth Nilsson, Helena Jernberg-Wiklund

Blood (2006) 107 (2): 669–678.

https://doi.org/10.1182/blood-2005-01-0306

Published: 2006

Includes: Supplemental data

Journal Articles

Expression of Erythropoietin Receptor (EPO-R) and In Vitro Functional Effects of Epoetin in B-Cell Malignancies.

Amir Abdalla, Parviz Kokhaei, Lotta Hansson, Manfred Kubbies, Anton Haselbeck, Eva Mikaelsson, Helena Jernberg-Wiklund, Håkan Mellstedt, Anders Österborg Österborg

Blood (2005) 106 (11): 4278.

https://doi.org/10.1182/blood.V106.11.4278.4278

Published: 2005

Journal Articles

Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells

Lina Y. Dimberg, Anna I. Dimberg, Karolina Ivarsson, Thomas Strömberg, Anders Österborg, Kenneth Nilsson, Fredrik Öberg, Helena Jernberg Wiklund

Blood (2005) 106 (4): 1346–1354.

https://doi.org/10.1182/blood-2004-04-1322

Published: 2005

Includes: Supplemental data

Journal Articles

Toward a rational combinaTORial therapy for multiple myeloma

Helena Jernberg-Wiklund, Kenneth Nilsson

Blood (2004) 104 (13): 3845–3846.

https://doi.org/10.1182/blood-2004-09-3648

Published: 2004

Journal Articles

Targeting the Insulin-Like Growth Factor-I Receptor (IGF-IR) in Multiple Myeloma Cells Using Selective IGF-IR Tyrosine Kinase Inhibitors.

Thomas Stromberg, PhD, Simon Ekman, MD, PhD, Leonard Girnita, PhD, Johan Lennartsson, Ulf Hellman, PhD, Kristina Carlson, MD, PhD, Anders Osterborg, MD, PhD, Karin Vanderkerken, PhD, Magnus Axelson, MD, PhD, Olle Larsson, MD, PhD, Kenneth Nilsson, MD, PhD, Helena Jernberg-Wiklund, PhD

Blood (2004) 104 (11): 639.

https://doi.org/10.1182/blood.V104.11.639.639

Published: 2004

Journal Articles

Inhibiting the IGF-1 Receptor Tyrosine Kinase with Picropodophillin: An In Vitro and In Vivo Study in the 5T33MM Mouse Model.

Karin Vanderkerken, PhD, Eline Menu, Thomas Stromberg, PhD, Hendrik De Raeve, MD, Kewal Asosingh, PhD, Ben Van Camp, MD, PhD, Helena Jernberg-Wiklund, PhD

Blood (2004) 104 (11): 640.

https://doi.org/10.1182/blood.V104.11.640.640

Published: 2004

Journal Articles

Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone

Thomas Strömberg, Anna Dimberg, Anna Hammarberg, Kristina Carlson, Anders Österborg, Kenneth Nilsson, Helena Jernberg-Wiklund

Blood (2004) 103 (8): 3138–3147.

https://doi.org/10.1182/blood-2003-05-1543

Published: 2004

Journal Articles

The Somatostatin Analog Octreotide Inhibits Growth of Interleukin-6 (IL-6)–Dependent and IL-6–Independent Human Multiple Myeloma Cell Lines

Patrik Georgii-Hemming, Thomas Strömberg, Eva Tiensuu Janson, Mats Stridsberg, Helena Jernberg Wiklund, Kenneth Nilsson

Blood (1999) 93 (5): 1724–1731.

https://doi.org/10.1182/blood.V93.5.1724

Published: 1999

Journal Articles

Fas/APO-1 (CD95)–Mediated Apoptosis Is Activated by Interferon-γ and Interferon- in Interleukin-6 (IL-6)–Dependent and IL-6–Independent Multiple Myeloma Cell Lines

Helena Spets, Patrik Georgii-Hemming, Jan Siljason, Kenneth Nilsson, Helena Jernberg-Wiklund

Blood (1998) 92 (8): 2914–2923.

https://doi.org/10.1182/blood.V92.8.2914

Published: 1998

NARROW

An Epigenomic Map of Multiple Myeloma Reveals the Importance of Polycomb Gene Silencing for the Malignancy

Recurrent Mutations within the Nfkbie gene: A Novel Mechanism for NF-κB Deregulation in Aggressive Chronic Lymphocytic Leukemia

The DNA Methyltransferase Inhibitor Decitabine Induces DNA Damage, Cell Cycle Arrest and Apoptosis in Multiple Myeloma

Combination of the IGF-1 Receptor Inhibitor Picropodophylin and the BH3 Mimetic ABT-737 Has Synergistic Anti-Myeloma Activity

ABT-737 Sensitizes B Cell Tumors for Killing by CD19-Retargeted T Cells,

IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms

Selective Inhibition of Glycogen Synthase Kinase-3 by Facilitators of Insulin Response Promotes Proliferation and Survival in Multiple Myeloma Cells.

Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model

IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G 2 /M-phase accumulation and apoptosis in multiple myeloma cells

Expression of Erythropoietin Receptor (EPO-R) and In Vitro Functional Effects of Epoetin in B-Cell Malignancies.

Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells

Toward a rational combinaTORial therapy for multiple myeloma

Targeting the Insulin-Like Growth Factor-I Receptor (IGF-IR) in Multiple Myeloma Cells Using Selective IGF-IR Tyrosine Kinase Inhibitors.

Inhibiting the IGF-1 Receptor Tyrosine Kinase with Picropodophillin: An In Vitro and In Vivo Study in the 5T33MM Mouse Model.

Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone

The Somatostatin Analog Octreotide Inhibits Growth of Interleukin-6 (IL-6)–Dependent and IL-6–Independent Human Multiple Myeloma Cell Lines

Fas/APO-1 (CD95)–Mediated Apoptosis Is Activated by Interferon-γ and Interferon- in Interleukin-6 (IL-6)–Dependent and IL-6–Independent Multiple Myeloma Cell Lines

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only